Corbus Pharmaceuticals

Corbus Pharmaceuticals company information, Employees & Contact Information

Corbus is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells. We are tenacious and will keep pushing the known boundaries to make breakthroughs where others have not.

Company Details

Employees
50
Founded
-
Address
500 River Ridge Dr, Norwood,massachusetts 02062,united States
Phone
(617) 963-0100
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Norwood, Massachusetts
Looking for a particular Corbus Pharmaceuticals employee's phone or email?

Corbus Pharmaceuticals Questions

News

Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium - GlobeNewswire

Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 - The Globe and Mail

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 The Globe and Mail

FDA Fast-Tracks Revolutionary Nectin-4 ADC: Corbus Pharma's CRB-701 Shows Promise in Head & Neck Cancer - Stock Titan

FDA Fast-Tracks Revolutionary Nectin-4 ADC: Corbus Pharma's CRB-701 Shows Promise in Head & Neck Cancer Stock Titan

Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25 - The Globe and Mail

Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25 The Globe and Mail

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) - PR Newswire

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) PR Newswire

Top Corbus Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant